Skip to content
Hs 611.T
Tissue
Lymph node
Disease
Hodgkin lymphoma
Metastatic site
Lymph node
Synonyms
Hs-611-T, Hs611T, HS611T

Documents

Hs 611.T

Cell line · Product number 305915

Hs 611.T is a human classical Hodgkin lymphoma (cHL) cell line established from the lymph node of a 48-year-old Caucasian female. The line is derived from...

€700.00excl. tax and shipping

Customization / Recommendations

In stock
Lot
Recommended (freshest lot)
  • CoA
1

01General information

Description

Hs 611.T is a human classical Hodgkin lymphoma (cHL) cell line established from the lymph node of a 48-year-old Caucasian female. The line is derived from the T-cell-rich nodular sclerosis subtype of Hodgkin lymphoma, one of the most common cHL subtypes. Hs 611.T grows in suspension with lymphoblast-like morphology. Hodgkin lymphoma-derived cell lines are relatively rare owing to the scarcity of the malignant Hodgkin Reed-Sternberg (HRS) cells within the tumor mass; Hs 611.T provides a valuable in vitro model of cHL biology.

Hs 611.T is applicable in Hodgkin lymphoma research including studies of HRS cell signaling, NF-κB pathway activity, JAK-STAT pathway regulation, surface antigen expression (including CD30, CD15, CD25), and responses to Hodgkin lymphoma-targeted therapies such as brentuximab vedotin (anti-CD30 ADC). The line is also used in immunological assays evaluating T cell suppression, cytokine secretion, and the tumor microenvironment interactions characteristic of cHL. As a BSL-2-classified cell line, it requires appropriate containment measures.

Tissue
Lymph node
Disease
Hodgkin lymphoma
Metastatic site
Lymph node
Applications
Hodgkin lymphoma research; NF-κB and JAK-STAT pathway studies; CD30/CD15/CD25 expression assays; brentuximab vedotin efficacy studies; tumor microenvironment; immunotherapy research
Synonyms
  • Hs-611-T
  • Hs611T
  • HS611T

02Classification

Organism
Human
Sex
Female
Growth properties
Suspension
Biosafety level
1

03Characteristics

Morphology
Lymphoblast-like
Cell type
B lymphoblast
Doubling time
approx. 24 to 48 hours

04Identifiers

Citation
Hs 611.T (Cytion catalog number 305915)
NCBI TaxID
9606
Cellosaurus
CVCL_0823

05Handling and culture

Culture medium
DMEM, w: 4.5 g/L Glucose, w: 4 mM L-Glutamine, w: 3.7 g/L NaHCO3, w: 1.0 mM Sodium pyruvate (Cytion article number 820300a)
Incubation atmosphere

37°C, 5% CO2, humidified atmosphere.

Supplements
Supplement the medium with 10% FBS
Dissociation reagent
None
Subculturing
Dilute the culture to 3–5 × 10⁵ cells/ml with fresh pre-warmed complete medium. Centrifugation (300×g, 5 min) may be used when medium exchange is required. Count viable cells before passaging to maintain optimal density. No enzymatic dissociation is required.
Split ratio
1 to 3
Seeding density
2 to 4 x 105 cells/ml
Fluid renewal
Every 2 to 3 days
Thawing and culturing
  1. Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.

  2. Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.

  3. For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.

  4. Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.

  5. Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.

  6. Centrifuge the mixture at 200 x g for 5 minutes, carefully discard the supernatant containing freezing medium.

  7. Follow the procedure described under Post-Thaw Recovery

06Quality control and cryopreservation

Freeze medium
As a cryopreservation medium, we use complete growth medium + 10% DMSO for adequate post-thaw viability.
Storage conditions

For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.

Shipping conditions

Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.

07Donor

Donor age
48 years
Ethnicity
Caucasian